TIRAP Rs8177376, Rs611953, Rs3802814, and Rs8177374 Polymorphisms and Their Association with Cervical Cancer Phenotype and Prognosis

Genes (Basel). 2022 Jul 29;13(8):1365. doi: 10.3390/genes13081365.

Abstract

Cervical cancer is one of the most common cancers in women worldwide, which is typically caused by human papillomavirus (HPV). Usually, the toll-like receptor (TLR) signaling pathways eliminate the virus from the organism, but in some cases, persistent infection may develop. Unfortunately, the mechanism of immune tolerance is still unclear. Therefore, this study aimed to analyze TIRAP rs8177376, rs611953, rs3802814, and rs8177374 polymorphisms and to identify their impact on cervical cancer phenotype and prognosis. This study included 172 cervical cancer patients. Genotyping was performed using the PCR-RFLP assay. Univariate and multivariate logistic regression and Cox's regression models were applied for statistical analysis. The results revealed that older age at the time of diagnosis was statistically linked with the rs8177376 T allele (OR = 2.901, 95% Cl 1.750-4.808, p = 0.000) and the rs611953 G allele (OR = 3.258, 95% Cl 1.917-5.536, p = 0.000). Moreover, the T allele of rs8177376 (OR = 0.424, 95% Cl 0.220-0.816, p = 0.010) was found to be statistically associated with the lower tumor grade. Thus, TIRAP polymorphisms might be employed in the future as potential biomarkers for determining the phenotype and prognosis of cervical cancer.

Keywords: TIRAP; cervical cancer; phenotype; polymorphisms; prognosis; survival; toll-like receptors.

MeSH terms

  • Case-Control Studies
  • Female
  • Humans
  • Membrane Glycoproteins / genetics
  • Phenotype
  • Polymorphism, Single Nucleotide
  • Prognosis
  • Receptors, Interleukin-1 / genetics
  • Uterine Cervical Neoplasms* / genetics

Substances

  • Membrane Glycoproteins
  • Receptors, Interleukin-1
  • TIRAP protein, human

Grants and funding

This research received no external funding.